A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

BACKGROUND: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a variety of symptoms including severe fatigue. The objective of the study was to examine the efficacy and safety of a TLR-3 agonist, rintatolimod (Poly I:...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Strayer, David R., Carter, William A., Stouch, Bruce C., Stevens, Staci R., Bateman, Lucinda, Cimoch, Paul J., Lapp, Charles W., Peterson, Daniel L., Mitchell, William M.
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2012
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3303772/
https://ncbi.nlm.nih.gov/pubmed/22431963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0031334
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים